Neurodegenerative disease is caused by the loss of neurons and/or their myelin sheath, which worsens over time and becomes dysfunctional.?
Neurodegenerative Diseases Drug Market contains market size and forecasts of Neurodegenerative Diseases Drug in Global, including the following market information:
- Global Neurodegenerative Diseases Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Neurodegenerative Diseases Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- By Drug Class Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Neurodegenerative Diseases Drug include Biogen, Pfizer, Roche, Novartis, Sanofi, Teva Pharmaceuticals, Orion Pharma Ltd, UCB S.A and ACADIA Pharmaceuticals Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Neurodegenerative Diseases Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurodegenerative Diseases Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Neurodegenerative Diseases Drug Market Segment Percentages, by Type, 2021 (%)
By Drug Class
- Immunomodulator
- Interferons
- Decarboxylase Inhibitors
- Dopamine Agonists
- Others
By Route of Administration
- Oral
- Injection
- Transdermal
Global Neurodegenerative Diseases Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Neurodegenerative Diseases Drug Market Segment Percentages, by Application, 2021 (%)
- Multiple Sclerosis
- Parkinson?s Disease
- Alzheimer?s Disease
- Spinal Muscular Atrophy (SMA)
- Others
Global Neurodegenerative Diseases Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Neurodegenerative Diseases Drug Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Neurodegenerative Diseases Drug revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Neurodegenerative Diseases Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Biogen
- Pfizer
- Roche
- Novartis
- Sanofi
- Teva Pharmaceuticals
- Orion Pharma Ltd
- UCB S.A
- ACADIA Pharmaceuticals Inc.
- Lundbeck Pharmaceuticals Italy S.p.A.
- Mitsubishi Tanabe Pharma America
Industry Market Size
